Aarti Drugs Limited (NSE:AARTIDRUGS)

Aarti Drugs Revenue

Aarti Drugs had revenue of 7.03B INR in the quarter ending June 30, 2026, with 19.01% growth. This brings the company's revenue in the last twelve months to 26.78B, up 10.54% year-over-year. In the fiscal year ending March 31, 2026, Aarti Drugs had annual revenue of 25.65B with 7.47% growth.

• Revenue (ttm): 26.78B
• Revenue Growth: +10.54%
• P/S Ratio: 1.49
• Revenue / Employee: 19.76M
• Employees: 1,355
• Market Cap: 39.82B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	25.65B	1.78B	7.47%
Mar 31, 2025	23.87B	-1.42B	-5.60%
Mar 31, 2024	25.29B	-1.87B	-6.90%
Mar 31, 2023	27.16B	2.27B	9.14%
Mar 31, 2022	24.89B	3.34B	15.49%

Data Source: S&P Global Market Intelligence Last updated: Jul 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 21, 2026

Data Sources Report a data error